Results 51 to 60 of about 1,262,593 (332)
Ki-67 expression in pulmonary tumors [PDF]
Translational Lung Cancer Research, 2016 Ki-67 was introduced more than two decades ago as a measure of the tumor proliferative fraction , in the need for a useful marker that might help clinicians to guide therapy and predict the prognosis of patients with cancer (1). Although several methods have been used to determine the tumor proliferative fraction in the research setting, the only ...
openaire +2 more sources
The cell proliferation antigen Ki-67 organises heterochromatin
eLife, 2016 Antigen Ki-67 is a nuclear protein expressed in proliferating mammalian cells. It is widely used in cancer histopathology but its functions remain unclear. Here, we show that Ki-67 controls heterochromatin organisation.
Michal Sobecki +20 more
doaj +1 more source
Scientific Reports, 2020 This retrospective analysis evaluated the interaction between Ki-67 and histological grade and their prognostic role in different breast cancer subtypes.
Qingmo Liang +3 more
semanticscholar +1 more source
Hypoxia and hyperglycaemia determine why some endometrial tumours fail to respond to metformin [PDF]
, 2020 High expression of Ki67, a proliferation marker, is associated with reduced endometrial cancer-specific survival. Pre-surgical metformin reduces tumour Ki-67 expression in some women with endometrial cancer. Metformin's anti-cancer activity may relate to
Crosbie, EJ +9 more
core +2 more sources
Clinical and Translational Medicine, 2020 Background and Aim To develop and validate radiomic prediction models using contrast-enhanced computed tomography (CE-CT) to preoperatively predict Ki-67 expression in gastrointestinal stromal tumors (GISTs). Method A total of 339 GIST patients from four
Qing-Wei Zhang +8 more
semanticscholar +1 more source
Metallothionein immunoexpression in non-syndromic and syndromic keratocystic odontogenic tumour [PDF]
, 2015 Background: To commpare the metallothionein (MT) immunoexpression in non-syndromic and syndromic keratocystic odontogenic tumour (KOT), to correlate MT with cellular proliferation, and to evaluate the influence of inflammation in MT.
Aguiar, Maria Cássia Ferreira +5 more
core +1 more source
Ki-67 expression in pulmonary tumors—reply [PDF]
Translational Lung Cancer Research, 2016 First of all, we would like to congratulate Professor Chirieac for his excellent discussion on proliferation assessment in lung tumors. Taken together, he concludes that assessment of proliferation is important for the prognosis of non-small cell lung cancer (NSCLC), prediction of brain metastases in patients with lung adenocarcinoma, and the diagnosis,
Mark, Kriegsmann, Arne, Warth
openaire +2 more sources
Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis [PDF]
, 2011 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Bhumsuk Keam +13 more
core +2 more sources
Frontiers in Molecular Biosciences, 2020 Objective To obtain molecular information in slides directly from H&E staining slides, which apparently display morphological information, to show that some differences in molecular level have already encoded in morphology.
Yiqing Liu +10 more
semanticscholar +1 more source
Comparison of the value of PCNA and Ki-67 as markers of cell proliferation in ameloblastic tumors [PDF]
, 2012 Objectives: The aim of this study was to compare among PCNAand Ki-67 as the most reliable immunohisto chemical marker for evaluating cell proliferation in ameloblastic tumors.
Bologna-Molina, Ronell +4 more
core +1 more source